Please ensure Javascript is enabled for purposes of website accessibility

Why These Top Marijuana Stocks Got Slammed Today

By Eric Volkman - Mar 16, 2021 at 6:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's about what's happening in a potentially powerful marijuana state.

What happened

It was a terrible Tuesday for most marijuana stocks, particularly the Canadian ones. Tilray (TLRY) sank by nearly 12%, while its partner-to-be Aphria (APHA) fell by 9%. Canopy Growth (CGC -12.07%), Aurora Cannabis (ACB -38.46%), Organigram Holdings (OGI -4.13%), and HEXO (HEXO -3.58%) were close behind, sliding at rates from 4% to 7%.

So what

If there's one thing investors despise, it's uncertainty. Tuesday's big question mark was New York, which is considered by many weed-watchers to be the next likely state to legalize recreational marijuana.

New York road sign with marijuana leaf.

Image source: Getty Images.

Yet on Tuesday, there were conflicting media reports about the state government's decision to flip the switch.

The Albany-based Times Union, for example, published an article that day headlined "Legislature nears deal on recreational marijuana legalization." Yet Marijuana Moment quoted state Senate majority leader Andrea Stewart-Cousins as saying negotiations over such legislation "reached a little bit of an impasse."

Now what

Much of this uncertainty can be attributed to the usual political horse-trading that goes into any significant piece of legislation. Most sensible New Yorkers -- even the politicians -- realize that the state is facing a budgetary chasm and desperately needs good tax revenue sources.

At the end of the day, for all the political noise, New York seems to be barreling straight toward recreational legalization. This might ultimately be the factor driving the prices of Canadian pot companies down; after all, it's their American peers that will be able to immediately pounce on the New York market, not them.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote
Tilray
TLRY
Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.68 (-38.46%) $-1.05
Canopy Growth Stock Quote
Canopy Growth
CGC
$4.88 (-12.07%) $0.67
OrganiGram Holdings Stock Quote
OrganiGram Holdings
OGI
$1.16 (-4.13%) $0.05
HEXO Stock Quote
HEXO
HEXO
$0.25 (-3.58%) $0.01
Aphria Stock Quote
Aphria
APHA

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
356%
 
S&P 500 Returns
124%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.